NCT05976581

Brief Summary

The goal of this prospective randomized study is to improve antibiotic use among hospitalized patients with suspected pneumonia. An alert was built into the electronic health record to guide use of diagnostic testing based on probability of bacterial pneumonia. Patients with test results suggesting viral infection will be randomized to either: (1) receive a structured communication from the antimicrobial stewardship team to de-escalate antibiotics or (2) usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 4, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

1.2 years

First QC Date

July 11, 2023

Last Update Submit

April 10, 2026

Conditions

Keywords

diagnostic stewardshipantimicrobial stewardship

Outcome Measures

Primary Outcomes (1)

  • Hospital antibiotic days of therapy

    The aggregate sum of days for which any amount of a specific antimicrobial agent was administered during the hospital encounter, from arrival in the emergency department or on the hospital ward until discharge.

    Up to 90 days after randomization

Secondary Outcomes (8)

  • Hospital length of stay

    Up to 90 days after randomization

  • In-hospital mortality

    Up to 90 days after randomization

  • Readmissions within 30-days of randomization

    Within 30 days after randomization

  • C. difficile infections in the 30-days post-randomization

    Within 30 days after randomization

  • Acute kidney injury

    Within 14 days of randomization

  • +3 more secondary outcomes

Study Arms (2)

Electronic alert plus structured communication of test results

EXPERIMENTAL

An electronic health record alert will guide diagnostic testing for pneumonia. For patients with low or moderate probability of bacterial pneumonia, test results will be communicated to the primary team with guidance to consider discontinuing or de-escalating antibiotics.

Behavioral: Electronic alertBehavioral: Structured communication of test results

Electronic alert without structured communication of test results

ACTIVE COMPARATOR

An electronic health record alert will guide diagnostic testing for pneumonia. The primary care team will access and interpret test results and decide upon composition and duration of antimicrobial without external guidance.

Behavioral: Electronic alert

Interventions

An alert will appear in the electronic health record that provides options for diagnostic testing based on low, medium, or high probability of bacterial pneumonia.

Electronic alert plus structured communication of test resultsElectronic alert without structured communication of test results

A clinical research team member will send an electronic message to the primary care team on behalf of the antimicrobial stewardship program with structured guidance to stop or de-escalate antibiotics and document these recommendations in the patient's chart.

Electronic alert plus structured communication of test results

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients admitted to the University of Maryland Medical Center or University of Maryland Medical Center-Midtown Campus who are prescribed antibiotics for suspected community-acquired respiratory infection.
  • Protocol-based diagnostic testing supports possible viral infection, either by positive molecular test or low procalcitonin value.

You may not qualify if:

  • Hospitalization for \>72 hours prior to protocol-based diagnostic testing.
  • Previous molecular testing for viral infection during the same hospital encounter.
  • Severely immunosuppressed, defined as having hematologic malignancy, solid organ tumor on chemotherapy, or solid organ transplant on immunosuppression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Maryland Medical Center - Midtown Campus

Baltimore, Maryland, 21201, United States

Location

University of Maryland Medical Center

Baltimore, Maryland, 21201, United States

Location

Related Publications (1)

  • Baghdadi JD, Harris AD, Pineles L, Al-Shanqeeti S, Palacio D, Charles DW, Heil E, Claeys KC, Bork JT, Sommerkamp S, Wilkerson RG, Godwin G, Sutherland ME, Johnson JK, Morgan DJ. Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients: A Pragmatic, Randomized Trial. Clin Infect Dis. 2026 Mar 13:ciag126. doi: 10.1093/cid/ciag126. Online ahead of print.

MeSH Terms

Conditions

PneumoniaPneumonia, ViralPneumonia, Bacterial

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesVirus DiseasesBacterial InfectionsBacterial Infections and Mycoses

Study Officials

  • Daniel J. Morgan, MD, MS

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: This study involves a randomized trial embedded within a quasi-experiment. During the 1-year study period, we anticipate that 1,500 patients will be exposed to the electronic health record modification performed as part of the quasi-experiment. Regarding the randomized trial, if 100 patients are enrolled during the 1-year study period, including 50 in intervention patients and 50 controls, we anticipate that we will have sufficient precision to estimate the difference in binary outcomes (e.g., antibiotic discontinuation within 5 days) between the two groups with a margin of error of approximately 15% based on a 95% confidence interval.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 11, 2023

First Posted

August 4, 2023

Study Start

November 1, 2023

Primary Completion

January 10, 2025

Study Completion

May 31, 2025

Last Updated

April 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations